STILDEM zolpidem tartrate 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

stildem zolpidem tartrate 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; hypromellose; magnesium stearate; titanium dioxide; macrogol 400 - short-term treatment of insomnia in adults.

APO-ZOLPIDEM zolpidem 10mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-zolpidem zolpidem 10mg tablet blister pack

arrotex pharmaceuticals pty ltd - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; hypromellose; hyprolose; macrogol 8000; titanium dioxide - short-term treatment of insomnia in adults.

ZOLPIDEM DR.REDDY'S Zolpidem tartrate 10mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zolpidem dr.reddy's zolpidem tartrate 10mg tablet blister pack

dr reddys laboratories australia pty ltd - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; hypromellose; magnesium stearate; titanium dioxide; macrogol 400 - short-term treatment of insomnia in adults.

ZOLPIDEM SANDOZ PHARMA zolpidem tartrate 10 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zolpidem sandoz pharma zolpidem tartrate 10 mg tablet blister pack

sandoz pty ltd - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; silicon dioxide; succinic acid; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - for the short-term treatment of insomnia in adults.

AZAPIN azathioprine 50 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

azapin azathioprine 50 mg tablet blister pack

arrotex pharmaceuticals pty ltd - azathioprine, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; mannitol; maize starch; povidone; croscarmellose sodium; sodium stearylfumarate; hypromellose; macrogol 400 - azathioprine is used as an immunosuppressant/antimetabolite either alone or, more commonly, in combination with the other agents (usually corticosteroids) and procedures which influence the immune response. therapeutic effects may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged usage of corticosteroids. azathioprine, in combination with corticosteroids and / or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. azathioprine, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following: severe rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis,/polymyositis, autoimmune chronic active hepatitis, pemphigus vulgaris, polyarteritis nodosa, autoimmune haemolytic anaemia, chronic refractory idiopathic thrombocytopenic purpura.

STILNOX Zolpidem tartrate 10mg tablet blister     pack Australia - English - Department of Health (Therapeutic Goods Administration)

stilnox zolpidem tartrate 10mg tablet blister pack

sanofi-aventis australia pty ltd - zolpidem tartrate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; sodium starch glycollate; macrogol 400; lactose monohydrate; microcrystalline cellulose; titanium dioxide - stilnox is indicated for the short term treatment of insomnia in adults (see section 4.2 dose and method of administration).

FARESTON toremifene (as citrate) 60mg tablet Australia - English - Department of Health (Therapeutic Goods Administration)

fareston toremifene (as citrate) 60mg tablet

orion pharma (aus) pty limited - toremifene citrate, quantity: 88.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; povidone; maize starch - for the first line treatment of hormone-dependent metastatic breast cancer in postmenopausal women. it is not recommended for patients with oestrogen receptor negative tumours.

NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

nolvadex-d tamoxifen 20mg (as citrate) tablet blister pack

astrazeneca pty ltd - tamoxifen citrate, quantity: 30.4 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; gelatin; titanium dioxide; maize starch; macrogol 300; hypromellose; magnesium stearate - treatment of breast cancer nolvadex-d is indicated for the treatment of breast cancer. primary reduction of breast cancer risk nolvadex-d is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

TAMOXIFEN SANDOZ tamoxifen 20mg (as citrate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tamoxifen sandoz tamoxifen 20mg (as citrate) tablet blister pack

sandoz pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; titanium dioxide; microcrystalline cellulose; povidone; hypromellose; macrogol 4000; magnesium stearate; sodium starch glycollate - treatment of breast cancer. ? tamoxifen sandoz is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk ? tamoxifen sandoz is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

GENOX 20 tamoxifen 20mg (as citrate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

genox 20 tamoxifen 20mg (as citrate) tablet blister pack

alphapharm pty ltd - tamoxifen citrate, quantity: 30.4 mg (equivalent: tamoxifen, qty 20 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; croscarmellose sodium; maize starch; mannitol - treatment of breast cancer. genox is indicated for the treatment of breast cancer. primary reduction of breast cancer risk. genox is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).